文献速递产科

术前静脉注射对乙酰氨基酚用于剖宫产术后镇痛:一项随机双盲安慰剂对照试验

Preoperative cesarean delivery intravenous acetaminophen treatment for postoperative pain control: a randomized double-blinded placebo control trial.
PubMed 文献 · Am J Obstet Gynecol · 2017-12-21

该前瞻性双盲随机安慰剂对照试验纳入105例择期剖宫产产妇,比较术前15分钟静脉输注1 g对乙酰氨基酚与安慰剂的效果,发现两组术后阿片类药物使用剂量、吗啡毫克当量、住院时长及疼痛评分均无显著差异,且脐带血对乙酰氨基酚水平均低于治疗浓度。

要点

  • 术前1 g静脉对乙酰氨基酚未减少剖宫产术后阿片类药物用量。
  • 两组术后住院时长和疼痛评分无差异。
  • 脐带血对乙酰氨基酚水平均低于治疗浓度。

核心结论

  • 剖宫产术前静脉给予1 g对乙酰氨基酚不减少术后阿片类药物剂量或吗啡毫克当量,也不缩短术后住院时长。
  • 术前1 g静脉对乙酰氨基酚不导致新生儿脐带血对乙酰氨基酚水平升高。

研究设计与样本

  • 前瞻性双盲随机安慰剂对照试验,2015年11月至2017年4月纳入择期剖宫产孕妇,目标至少100例(每组50例),实际评估105例。
  • 干预组51例接受术前15分钟静脉输注对乙酰氨基酚1000 mg(1 g),对照组54例接受等量生理盐水安慰剂,均由药房配发无标记的100 mL输液袋。
  • 排除标准为母体对乙酰氨基酚过敏、24小时内使用过对乙酰氨基酚、阿片类药物使用障碍及肝炎/肝损伤。

主要发现

  • 术后阿片类药物给药次数:对乙酰氨基酚组11.1(±8.9)次 vs 安慰剂组10.5(±8.5)次,P = .72。
  • 术后吗啡毫克当量:对乙酰氨基酚组94.2(±40.4) vs 安慰剂组90.7(±42.1),P = .67。
  • 两组住院时长和疼痛评分无差异。
  • 所有脐带血对乙酰氨基酚值均低于治疗浓度。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The United States currently has an opioid use disorder epidemic and research evaluating ways to minimize the use of opioids postsurgery are needed. One of these options is intravenous acetaminophen. If the use of preoperative intravenous acetaminophen was found to be effective for cesarean delivery, this would be beneficial for both the mother and breast-feeding neonate. OBJECTIVE: The primary study objective was to see if maternal opioid use was significantly less in the postoperative period for the study group that received 1 g of intravenous acetaminophen preoperatively compared with a control group that received placebo. The secondary objectives were to evaluate maternal length of stay and pain scores postoperatively, and assess the acetaminophen level in cord blood at delivery. STUDY DESIGN: This study was a prospective double-blinded randomized placebo-controlled trial. All pregnant patients who entered labor and delivery for a scheduled cesarean from November 2015 through April 2017 were eligible. Once consented, the medication was supplied by the pharmacy department, which performed the blinded randomization. Both the study drug of 1000 mg (1 g) of acetaminophen and placebo of normal saline were distributed as unmarked 100-mL bags administered over 15 minutes just prior to incision. No study personnel from the obstetric or anesthesia departments had any access to the randomization. Based on a power analysis using the published surgical data results, the goal was to obtain a minimum of 100 patients (50 patients in each arm). Primary data collection included demographics, number of opioid doses and morphine milligram equivalents administered to the patient postoperatively, length of stay postdelivery, pain scores, and newborn cord blood acetaminophen levels. Exclusions were maternal acetaminophen allergy, receipt of acetaminophen in the prior 24 hours, opioid use disorder, and hepatitis/liver impairment. Statistics involved χ2, Fisher exact, and the Student t test where appropriate and a P value <.05 was considered significant with all tests considered against a 2-sided alternative hypothesis. RESULTS: A total of 105 patients were evaluated with 51 who received intravenous acetaminophen and 54 who received placebo. The number of postoperative opioid medication doses administered to the study group was 11.1 (±8.9) compared with the number received by the control group of 10.5 (±8.5), P = .72. The morphine milligram equivalents in the study group was 94.2 (±40.4) compared with the control group of 90.7 (±42.1), P = .67. The length of stay and pain scores were not different between the groups. All of the umbilical cord blood values for acetaminophen were subtherapeutic. CONCLUSION: These data demonstrate that for cesarean delivery, the use of a preoperative 1-g intravenous dose of acetaminophen does not decrease the number of opioid medication doses or the morphine milligram equivalents administered postoperatively, nor does it decrease length of stay postcesarean. The administration of 1-g intravenous acetaminophen preoperatively does not result in elevated newborn cord blood levels (ClinicalTrials.govNCT02694653).

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Towers CV, Shelton S, van Nes J, et al. Preoperative cesarean delivery intravenous acetaminophen treatment for postoperative pain control: a randomized double-blinded placebo control trial. Am J Obstet Gynecol. 2017. PMID: 29274831. doi:10.1016/j.ajog.2017.12.203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。